|
Notification regarding unquoted securities - COO
|
27 June 2023 at 4:25pm
|
|
Further Update on Legal Proceedings
|
5 June 2023 at 9:10am
|
|
Further update on legal proceedings
|
1 June 2023 at 9:05am
|
|
Further update on legal proceedings
|
26 May 2023 at 9:15am
|
|
Further Update on Legal Proceedings
|
8 May 2023 at 9:25am
|
|
Update on Legal Proceedings
|
21 April 2023 at 2:05pm
|
|
Trading Halt
|
21 April 2023 at 9:55am
|
|
Results Release and Investor Presentation
|
24 February 2023 at 9:20am
|
|
Half Yearly Report and Accounts
|
24 February 2023 at 9:15am
|
|
Notice of Results Announcement
|
15 February 2023 at 9:00am
|
|
Notification regarding unquoted securities - COO
|
1 December 2022 at 9:55am
|
|
Update on Legal Proceedings relating to PharmX
|
25 November 2022 at 8:55am
|
|
Amendment to the Constitution
|
14 November 2022 at 4:50pm
|
|
Results of Annual General Meeting
|
14 November 2022 at 12:50pm
|
|
Chair's Presentation to the AGM
|
14 November 2022 at 10:20am
|
|
Application for quotation of securities - COO
|
2 November 2022 at 12:10pm
|
|
Notice of Annual General Meeting/Proxy Form
|
12 October 2022 at 9:30am
|
|
Key AGM Dates
|
13 September 2022 at 4:55pm
|
|
Investor Presentation FY22
|
5 September 2022 at 9:15am
|
|
FY22 Results Release
|
30 August 2022 at 9:15am
|
|
Appendix 4G and Corporate Governance Statement
|
30 August 2022 at 9:10am
|
|
Appendix 4E and Annual Report
|
30 August 2022 at 9:00am
|
|
PharmX Launches PharmXchange Platform
|
22 June 2022 at 9:10am
|
|
Sigma signs long term PharmX agreement
|
3 May 2022 at 10:05am
|
|
Notification of cessation of securities - COO
|
30 March 2022 at 3:35pm
|
|
Corum completes sale of Real Estate eCommerce business unit
|
29 March 2022 at 8:55am
|
|
H1 FY22 Interim Media Release and Results Presentation
|
10 February 2022 at 9:35am
|
|
Half Yearly Report and Accounts
|
10 February 2022 at 9:35am
|
|
PharmX Agreement - Supplementary Information
|
8 February 2022 at 9:45am
|
|
Symbion & ProPharma sign long term PharmX agreement
|
7 February 2022 at 9:40am
|
|
Notice of Results Announcement
|
4 February 2022 at 9:55am
|
|
Notification of cessation of securities - COO
|
1 February 2022 at 1:25pm
|
|
Final Director's Interest Notice - J Sallabank
|
1 February 2022 at 9:55am
|
|
Resignation of Managing Director
|
1 February 2022 at 9:55am
|
|
Corum Agrees Sale of eCommerce Business Unit
|
20 December 2021 at 10:45am
|
|
Notification regarding unquoted securities - COO
|
10 December 2021 at 4:45pm
|
|
Trading Update
|
8 December 2021 at 5:25pm
|
|
Update on Legal Proceedings relating to PharmX
|
7 December 2021 at 9:50am
|
|
Results of Annual General Meeting
|
24 November 2021 at 1:20pm
|
|
Chairman & CEO Address and AGM Presentation
|
24 November 2021 at 10:45am
|
|
Key Retail Pharmacy Groups signed on to drive PharmX growth
|
23 November 2021 at 12:40pm
|
|
Corum Trading Update
|
29 October 2021 at 9:45am
|
|
Notice of General Meeting/Proxy Form
|
22 October 2021 at 12:50pm
|
|
2021 Annual General Meeting Key Dates
|
10 September 2021 at 9:35am
|
|
Corum extends relationship with Sigma into WholeLife
|
2 September 2021 at 9:35am
|
|
Press Release and Investor Presentation
|
18 August 2021 at 9:15am
|
|
Appendix 4G and Corporate Governance Statement
|
18 August 2021 at 9:15am
|
|
Appendix 4E and Annual Report
|
18 August 2021 at 9:15am
|
|
Notice of Results Announcement and Investor Presentation
|
10 August 2021 at 5:40pm
|
|
Investor Presentation
|
3 August 2021 at 5:15pm
|
Corum Group